~~<i id='B9EE3F0E29'><strike id='B9EE3F0E29'><tt id='B9EE3F0E29'><pre id='B9EE3F0E29'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

knowledge

author：fashion 2025-09-28 01:38:52 - browse：16843

In a dark grey suit and light blue button-down shirt, Bill Sibold, CEO of Madrigal Pharmaceuticals, smiles— coverage from STAT — Madrigal CEO Bill Sibold says the company is "interested in the patients who are most in need." Madrigal Pharmaceuticals

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week.

The pill, called resmetirom, is made by Madrigal Pharmaceuticals.

Metabolic dysfunction-associated steatohepatitis, or MASH and previously called NASH, is often associated with obesity. The accumulation of fat in the liver causes inflammation, which leads to fibrosis, or liver scarring, and can progress in more advanced stages to cirrhosis, cancer, and the need for a liver transplant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： House looks to weaken Medicare negotiation

knowledge

leisure time

focus

Wikipedia

focus

AscreenattheNewYorkStockExchangelastNovember.MichaelM.Santiago/GettyImagesPfizerspentmorethanfourhou

WSS

Pfizer highlights cancer drugs it thinks could reignite investor interest

New case study details death in closely watched Alzhiemer's trial

Biotech companies concerned about China biosecurity crackdown

Bacterial infection may be ‘key event’ in endometriosis, study says

Doctor appointment wait times are getting worse

FogPharma raises $145 million in rare Series E round

explore

knowledge

knowledge

Medicare details structure of new drug price negotiation program

Kale crackers and hibiscus tea: My five days on a 'fasting diet'

State Dept. review finds Biden bears some blame for Afghanistan failures

How to fix the rural physician shortage in the U.S.

Malaria cases in Florida and Texas: Here’s what you need to know

Grail is spending more than ever lobbying Congress

Walensky prepares to leave CDC — and Congress — behind

An inside look at PIPEs, biotech's buzzy new financing tool

Medical leaders decry Supreme Court decision on affirmative action

When is a doctor not a doctor? Try when patients address women doctors

leisure time

ALS groups 'won't be played again' by the FDA, drug sponsors

Covid isolation guidance eased by the CDC

When is a doctor not a doctor? Try when patients address women doctors

International team creates first chimeric human

Option Care buys Amedisys in $3.6 billion home care deal

https://cbu01.alicdn.com/img/ibank/2017/652/090/4524090256_306409539.220x220xz.jpg

focus

focus

Wikipedia

focus